DETERMINANTS OF POOR FUNCTIONAL OUTCOMES; AFTER INTRAVENOUS THROMBOLYSIS IN ACUTE ISCHEMIC STROKE: INSIGHTS FROM A TERTIARY CARE HOSPITAL IN PAKISTAN
Main Article Content
Keywords
Acute ischemic stroke, intravenous thrombolysis, stroke prognosis, functional outcomes, NIHSS, ASPECTS, symptom-to-needle time, predictive modeling.
Abstract
Purpose
Intravenous thrombolysis (IVT) is the gold standard treatment for eligible patients with acute ischemic stroke (AIS), significantly improving functional outcomes when administered within the recommended therapeutic window. However, despite timely intervention, a considerable proportion of patients experience poor recovery. This study aims to identify clinical, radiological, and demographic determinants of poor functional outcomes in AIS patients who received IVT at a tertiary care hospital in Pakistan. By recognizing these predictors, we seek to enhance risk stratification, optimize post-stroke care, and improve patient management strategies in resource-limited settings.
Materials and Methods
This retrospective observational study was conducted at Ayub Teaching Hospital, Abbottabad, Pakistan, including all adult patients (≥18 years) diagnosed with AIS who received IVT within 4.5 hours of symptom onset between July 2023 and March 2024. Data were collected retrospectively from medical records, including baseline demographics, stroke severity (NIHSS score), comorbidities, neuroimaging findings, in-hospital complications, and discharge status. Functional outcomes were assessed using the modified Rankin Scale (mRS) at 90 days, classifying patients into good (mRS 0–2) and poor (mRS 3–6) outcome groups. Univariable and multivariable logistic regression analyses were performed to determine independent predictors of poor functional outcomes. A predictive model was developed based on significant variables, and its accuracy was validated using receiver operating characteristic (ROC) curve analysis. The findings from this study will provide valuable insights into post-thrombolysis outcomes in the local population, aiding in the development of targeted interventions for better stroke recovery.
Results
A total of 152 patients who received intravenous thrombolysis (IVT) for acute ischemic stroke (AIS) at Ayub Teaching Hospital, Abbottabad, were included. The mean age was 62.3 ± 11.5 years, with a male predominance (58.6%). At the 90-day follow-up, 98 patients (64.5%) had good functional outcomes (modified Rankin Scale [mRS] 0–2), while 54 (35.5%) had poor outcomes (mRS 3–6), including 12 (7.9%) mortalities. Multivariable logistic regression identified older age (AOR 1.05; 95% CI 1.01–1.09; P = 0.04), hypertension (AOR 3.21; 95% CI 1.45–7.12; P = 0.005), higher admission NIHSS (AOR 1.12; 95% CI 1.04–1.20; P = 0.002), symptom-to-needle time > 180 minutes (AOR 2.89; 95% CI 1.32–6.31; P = 0.008), and lower ASPECTS (AOR 0.61; 95% CI 0.42–0.89; P = 0.01) as independent predictors of poor functional outcomes. The predictive model demonstrated strong accuracy, with an area under the receiver operating characteristic curve (AuROC) of 0.826 (95% CI 0.755–0.897). Subgroup analysis showed significantly worse outcomes in patients aged ≥ 65 years (OR 2.74, P = 0.006), NIHSS ≥ 15 (OR 4.2, P < 0.001), and symptom-to-needle time > 180 minutes. These findings highlight the importance of early intervention and risk stratification in AIS patients receiving IVT.
Conclusion
This study highlights that older age, hypertension, higher baseline NIHSS, prolonged symptom-to-needle time, and lower ASPECTS on initial brain imaging are significant predictors of poor functional outcomes following IVT in acute ischemic stroke patients. These findings emphasize the need for early intervention, optimized blood pressure control, and rapid thrombolysis administration to improve post-stroke recovery. Future prospective studies are warranted to validate these predictors and refine patient selection criteria for IVT in resource-limited settings.
References
2. Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association. Circulation. 2019;139(10):e56-e528. doi:10.1161/CIR.0000000000000659
3. Kamal AK, Itrat A, Murtaza M, et al. Stroke in Pakistan: findings from a national survey. Journal of the Pakistan Medical Association. 2016;66(9 Suppl 1):S11-S15.
4. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients with Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines. Stroke. 2019;50(12):e344-e418. doi:10.1161/STR.0000000000000211
5. Boulanger JM, Lindsay MP, Gubitz G, et al. Canadian Stroke Best Practice Recommendations for Acute Stroke Management: 6th Edition, Update 2018. International Journal of Stroke. 2018;13(9):949-984. doi:10.1177/1747493018786616
6. Menon BK, Saver JL. Predictors of Reperfusion Success and Clinical Outcomes in Acute Ischemic Stroke. Stroke. 2015;46(10):2973-2978. doi:10.1161/STROKEAHA.115.010722
7. Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischemic stroke: a meta-analysis of individual patient data from randomized trials. The Lancet. 2014;384(9958):1929-1935. doi:10.1016/S0140-6736(14)60584-5
8. Reeves MJ, Bushnell CD, Howard G, et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. The Lancet Neurology. 2008;7(10):915-926. doi:10.1016/S1474-4422(08)70193-5
9. Ovbiagele B, Nguyen-Huynh MN. Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics. 2011;8(3):319-329. doi:10.1007/s13311-011-0053-1
10. O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. The Lancet. 2010;376(9735):112-123. doi:10.1016/S0140-6736(10)60834-3
11. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy (ASPECTS). The Lancet. 2000;355(9216):1670-1674. doi:10.1016/S0140-6736(00)02237-6
12. Pandian JD, Sudhan P. Stroke Epidemiology and Stroke Care Services in India. Journal of Stroke. 2013;15(3):128-134. doi:10.5853/jos.2013.15.3.128
13. Meretoja A, Strbian D, Mustanoja S, et al. Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology. 2012;79(4):306-313. doi:10.1212/WNL.0b013e31825d6011
14. Kent DM, Ruthazer R, Sharma M, et al. Risk models for predicting post-thrombolytic hemorrhage: a systematic review and validation study. Stroke. 2013;44(12):3073-3079. doi:10.1161/STROKEAHA.113.002552
15. Hankey GJ. Secondary stroke prevention. The Lancet Neurology. 2014;13(2):178-194. doi:10.1016/S1474-4422(13)70255-2